Twitter
youtube
Discord
Contact us
Menu
Forums
New posts
Trending
Rules
Explore
Bioenergetic Wiki
Bioenergetic Life Search
Bioprovement Peat Search
Ray Peat Interviews by Danny Roddy
Master List: Ray Peat, PhD Interviews & Quotes by FPS
Traveling Resources
Google Flights
Wiki Voyage
DeepL Translator
Niche
Numbeo
Merch
Log in
Register
What's new
Search
Search
Search engine:
Threadloom Search
XenForo Search
Search titles only
By:
New posts
Trending
Menu
Log in
Register
Navigation
More options
Light/Dark Mode
Contact us
Close Menu
Forums
Information
World News
Pfizer to offer low-cost medicines, vaccines to poor nations
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="WPLG" data-source="post: 31618" data-attributes="member: 158"><p>Pfizer said Wednesday that it will provide nearly two dozen products, including its top-selling <a href="https://apnews.com/hub/coronavirus-pandemic?utm_source=apnewsnav&utm_medium=featured" target="_blank">COVID-19 vaccine</a> and treatment, at not-for-profit prices in some of the world’s poorest countries.</p><p></p><p>The drugmaker announced the program at the World Economic Forum’s annual gathering in Davos, Switzerland, and said it was aimed at improving health equity in 45 lower-income countries. Most of the countries are in Africa, but the list also includes Haiti, Syria, Cambodia and North Korea.</p><p></p><p>The products, which are widely available in the U.S. and the European Union, include 23 medicines and vaccines that treat infectious diseases, some cancers and rare and inflammatory conditions. Company spokeswoman Pam Eisele said only a small number of the medicines and vaccines are currently available in the 45 countries.</p><p></p><p>New York-based Pfizer will charge only manufacturing costs and “minimal” distribution expenses, Eisele said. It will comply with any sanctions and all other applicable laws.</p><p></p><p>The drugmaker also plans to provide help with public education, training for health care providers and drug supply management.</p><p></p><p>“What we discovered through the pandemic was that supply was not enough to resolve the issues that these countries are having,” Pfizer Chairman and CEO Albert Bourla said Wednesday during a talk at Davos.</p><p></p><p>He noted that billions of doses of the company's COVID-19 vaccine, Comirnaty, have been offered for free to low-income countries, mainly through the U.S. government, but those doses can't be used right now.</p><p></p><p>Earlier this month, the head of the World Health Organization called on Pfizer to make its COVID-19 treatment more widely available in poorer countries.</p><p></p><p>Comirnaty brought in nearly $37 billion in sales last year, and analysts expect the company's COVID-19 treatment Paxlovid to add almost $24 billion this year, according to the data firm FactSet.</p><p></p><p>___</p><p></p><p>The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.</p><p></p><p><a href="https://www.local10.com/business/2022/05/25/pfizer-to-offer-low-cost-medicines-vaccines-to-poor-nations/" target="_blank">Continue reading...</a></p></blockquote><p></p>
[QUOTE="WPLG, post: 31618, member: 158"] Pfizer said Wednesday that it will provide nearly two dozen products, including its top-selling [URL='https://apnews.com/hub/coronavirus-pandemic?utm_source=apnewsnav&utm_medium=featured']COVID-19 vaccine[/URL] and treatment, at not-for-profit prices in some of the world’s poorest countries. The drugmaker announced the program at the World Economic Forum’s annual gathering in Davos, Switzerland, and said it was aimed at improving health equity in 45 lower-income countries. Most of the countries are in Africa, but the list also includes Haiti, Syria, Cambodia and North Korea. The products, which are widely available in the U.S. and the European Union, include 23 medicines and vaccines that treat infectious diseases, some cancers and rare and inflammatory conditions. Company spokeswoman Pam Eisele said only a small number of the medicines and vaccines are currently available in the 45 countries. New York-based Pfizer will charge only manufacturing costs and “minimal” distribution expenses, Eisele said. It will comply with any sanctions and all other applicable laws. The drugmaker also plans to provide help with public education, training for health care providers and drug supply management. “What we discovered through the pandemic was that supply was not enough to resolve the issues that these countries are having,” Pfizer Chairman and CEO Albert Bourla said Wednesday during a talk at Davos. He noted that billions of doses of the company's COVID-19 vaccine, Comirnaty, have been offered for free to low-income countries, mainly through the U.S. government, but those doses can't be used right now. Earlier this month, the head of the World Health Organization called on Pfizer to make its COVID-19 treatment more widely available in poorer countries. Comirnaty brought in nearly $37 billion in sales last year, and analysts expect the company's COVID-19 treatment Paxlovid to add almost $24 billion this year, according to the data firm FactSet. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. [url="https://www.local10.com/business/2022/05/25/pfizer-to-offer-low-cost-medicines-vaccines-to-poor-nations/"]Continue reading...[/url] [/QUOTE]
Loading…
Insert quotes…
Verification
Post reply
Forums
Information
World News
Pfizer to offer low-cost medicines, vaccines to poor nations
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top